Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMBCHOP: Lubiprostone for Gut Permeability in HIV
NCT01839734Phase 2Completed
- Sponsor
- Ruth M. Rothstein CORE Center
- Start
- Jun 2013
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cobiprostone in human immunodeficiency virus infection (HIV), sponsored by Ruth M. Rothstein CORE Center. Started Jun 2013; status: completed.
02
Drugs
cobiprostone
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01839734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839734.